| |
|
|
|
|
|
|
|||
|
Blood, 15 November 2004, Vol. 104, No. 10, pp. 3285-3293. Prepublished online as a Blood First Edition Paper on July 22, 2004; DOI 10.1182/blood-2004-03-0900.
Submitted March 25, 2004
Department of Laboratory of Membrane biochemistry and biophysics, Kyoto University, Graduate School of Biostudies, Kyoto, Japan * Corresponding author; email: toshiroo{at}kuhp.kyoto-u.ac.jp.
IL-2 rescued human natural killer (NK) KHYG-1cells from apoptosis along with a reduction of ceramide. Conversely, an increase of ceramide inhibited IL-2-rescued survival. IL-2 deprivation-induced activation of acid sphingomyelinase (SMase) and inhibition of glucosylceramide synthase (GCS) and sphingomyelin synthase (SMS), were normalized by IL-2 supplementation. A PI-3 kinase inhibitor, LY294002 inhibited IL-2-rescued survival, but a mitogen-activated protein kinase inhibitor, PD98059 and an inhibitor of janus tyrosine kinase/signal transducer and activator of transcription pathway, AG490 did not. LY294002 inhibited IL-2-induced reduction of ceramide through activation of acid SMase and inhibition of GCS and SMS, suggesting the positive involvement of PI-3 kinase in ceramide reduction through enzymatic regulation. Indeed, a constitutively active PI-3 kinase enhanced growth rate and ceramide reduction through inhibition of acid SMase and activation of GCS and SMS. Further, LY294002 inhibited IL-2-induced changes of transcriptional level as well as mRNA and protein levels in acid SMase and GCS, but did not affect the stability of the mRNAs. These results suggest that PI-3 kinase-dependent reduction of ceramide through regulation of acid SMase, GCS and SMS play a role in IL-2-rescued survival of NK cells.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||